Pharm
CD30 Monoclonal Antibody
search
CD30 Monoclonal Antibody
, CD30 Antigen, Brentuximab vedotin, Adcetris
See Also
Monoclonal Antibody-Mediated Chemotherapy
Targeted Cancer Therapy
Chemotherapy
Monoclonal Antibody
Indications
Hodgkins
Lymphoma
Brentuximab vedotin
Systemic Anaplastic Large Cell
Lymphoma
Brentuximab vedotin
Mechanism
CD30
CD30 is a
Tumor Necrosis Factor
(TNF) receptor found on the surface of
White Blood Cell
s
CD30 is overexpressed in hematopoietic malignancies
CD30 Monoclonal Antibody
Conjugate antibodies that deliver cytotoxic drugs to CD30 positive cancer cells
Medications
Brentuximab vedotin (Adcetris)
Conjugated
Monoclonal Antibody
that delivers the cytotoxic drug monomethyl auristatin E (MMAE) to cancer cells
Used in Hodgkins
Lymphoma
Dosing
See other references for disease specific dosing protocols
Adverse Effects
Peripheral Neuropathy
Infusion reactions (including
Anaphylaxis
)
Cytopenia
Neutropenia
Lymph
openia
Thrombocytopenia
Immunosuppression
Risk of opportunistic infections
Hepatotoxicity
Tumor Lysis Syndrome
Pulmonary toxicity
Severe dermatologic conditions
Stevens-Johnson Syndrome
Toxic Epidermal Necrolysis
Other common adverse effects
Hyperglycemia
Gastrointestinal effects (
Nausea
,
Vomiting
,
Diarrhea
,
Constipation
,
Abdominal Pain
, weight loss)
Stomatitis
and mucositis
Alopecia
Safety
Avoid in
Lactation
Avoid in pregnancy (all trimesters, Unknown Pregnancy category)
Use reliable
Contraception
Monitoring
Complete Blood Count
Liver Function Test
s (including
Serum Bilirubin
)
Drug Interactions
Bleomycin
Avoid in combination with Brentuximab (risk of pulmonary toxicity)
Resources
Brentuximab (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f
Type your search phrase here